Junfeng Xu

400 total citations
27 papers, 270 citations indexed

About

Junfeng Xu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Junfeng Xu has authored 27 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Junfeng Xu's work include Colorectal Cancer Screening and Detection (6 papers), Genetic factors in colorectal cancer (6 papers) and Immune cells in cancer (4 papers). Junfeng Xu is often cited by papers focused on Colorectal Cancer Screening and Detection (6 papers), Genetic factors in colorectal cancer (6 papers) and Immune cells in cancer (4 papers). Junfeng Xu collaborates with scholars based in China, United States and Australia. Junfeng Xu's co-authors include Lang Yang, Peng Jin, Jianqiu Sheng, Yuqi He, Qian Kang, Yuanming Pan, Dezhi Wang, Jianguo Chen, Fang Wang and Pengfei Wu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biological Psychiatry.

In The Last Decade

Junfeng Xu

25 papers receiving 267 citations

Peers

Junfeng Xu
Xinyi Cao China
Di Xia China
Xiyin Wang United States
Michael Petr Denmark
George S. Bounoutas United States
Xinyi Cao China
Junfeng Xu
Citations per year, relative to Junfeng Xu Junfeng Xu (= 1×) peers Xinyi Cao

Countries citing papers authored by Junfeng Xu

Since Specialization
Citations

This map shows the geographic impact of Junfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Xu more than expected).

Fields of papers citing papers by Junfeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Xu. The network helps show where Junfeng Xu may publish in the future.

Co-authorship network of co-authors of Junfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Xu. A scholar is included among the top collaborators of Junfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Xu. Junfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Junfeng, Na Li, Ruoran Li, et al.. (2025). CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment. Translational Oncology. 53. 102310–102310. 2 indexed citations
2.
Li, Borui, Ting Wang, Haifeng Hu, et al.. (2025). Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity in pancreatic ductal adenocarcinoma. Acta Pharmacologica Sinica. 46(6). 1742–1756. 4 indexed citations
3.
Wang, Xuexin, Zhijun Zheng, Dongliang Yu, et al.. (2025). Colorectal cancer in Lynch syndrome families: consequences of gene germline mutations and the gut microbiota. Orphanet Journal of Rare Diseases. 20(1). 30–30. 1 indexed citations
4.
Fu, Yanxia, Bo Xie, Yinyin Wang, et al.. (2025). CD126hi umbilical cord mesenchymal stem cells sensitive to IL-6 ameliorate inflammatory bowel disease by producing TGF-β1. Orphanet Journal of Rare Diseases. 20(1). 458–458.
5.
Li, Mengdi, Xiaolin Duan, Yinyin Wang, et al.. (2025). Regulation of revival stem cell differentiation by CREPT/RPRD1B during intestinal regeneration. Cell & Bioscience. 15(1). 98–98. 1 indexed citations
7.
Zhai, Huihong, Dongliang Yu, Lang Yang, et al.. (2024). Standard-definition White-light, High-definition White-light versus Narrow-band Imaging Endoscopy for Detecting Colorectal Adenomas: A Multicenter Randomized Controlled Trial. Current Medical Science. 44(3). 554–560. 2 indexed citations
8.
Zhang, Xiaoyu, Aoran Fan, Xiang‐Qian Liu, et al.. (2023). A novel detection technology for early gastric cancer based on Raman spectroscopy. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 292. 122422–122422. 16 indexed citations
9.
Xu, Junfeng, Peng Jin, Lang Yang, et al.. (2023). Serum metabolomics of hyperbilirubinemia and hyperuricemia in the Tibetan plateau has unique characteristics. Scientific Reports. 13(1). 6 indexed citations
10.
Fu, Yanxia, Chen Zhang, Ziyu Wang, et al.. (2023). Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation. Life Sciences. 334. 122189–122189. 10 indexed citations
11.
Xu, Junfeng, Zhijun Zheng, Lang Yang, et al.. (2022). A novel promising diagnosis model for colorectal advanced adenoma and carcinoma based on the progressive gut microbiota gene biomarkers. Cell & Bioscience. 12(1). 208–208. 10 indexed citations
12.
Xu, Junfeng, Fang Gu, You Peng, et al.. (2022). Asia-Pacific Colorectal Screening Score Combined With Stool DNA Test Improves the Detection Rate for Colorectal Advanced Neoplasms. Clinical Gastroenterology and Hepatology. 21(6). 1627–1636.e4. 7 indexed citations
13.
Jin, Peng, You Peng, Jing‐Yuan Fang, et al.. (2021). Comparison of Performance of Two Stool DNA Tests and a Fecal Immunochemical Test in Detecting Colorectal Neoplasm: A Multicenter Diagnostic Study. Cancer Epidemiology Biomarkers & Prevention. 31(3). 654–661. 11 indexed citations
14.
Gao, Meng, Juan An, Xin Wang, et al.. (2020). <p>Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer</p>. OncoTargets and Therapy. Volume 13. 8475–8493. 10 indexed citations
15.
Pan, Yuanming, Xin Wang, Yuqi He, et al.. (2020). Tumor suppressor ATP4B serve as a promising biomarker for worsening of gastric atrophy and poor differentiation. Gastric Cancer. 24(2). 314–326. 10 indexed citations
16.
He, Jin‐Gang, Hai-Yun Zhou, Junfeng Xu, et al.. (2020). Transcription Factor TWIST1 Integrates Dendritic Remodeling and Chronic Stress to Promote Depressive-like Behaviors. Biological Psychiatry. 89(6). 615–626. 44 indexed citations
17.
Xu, Junfeng, Qian Kang, Yuanming Pan, et al.. (2018). A Novel Method to Detect Early Colorectal Cancer Based on Chromosome Copy Number Variation in Plasma. Cellular Physiology and Biochemistry. 45(4). 1444–1454. 27 indexed citations
18.
Yang, Lang, Junfeng Xu, Qian Kang, et al.. (2017). Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage. PLoS ONE. 12(1). e0169124–e0169124. 17 indexed citations
19.
Xu, Junfeng, Lang Yang, Peng Jin, & Jianqiu Sheng. (2016). Endoscopic Approach for Superficial Colorectal Neoplasms. PubMed. 3(2). 69–80. 8 indexed citations
20.
Guo, Lin, Junfeng Xu, & Jian Liu. (2010). Electroacupuncture, Calpain I Expression, and Survival of Hippocampal Neurons in Cerebral Ischemia Reperfusion Rats. Medical Acupuncture. 22(2). 99–104. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026